{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "16636635", "DateCompleted": {"Year": "2006", "Month": "10", "Day": "03"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0033-3190", "JournalIssue": {"Volume": "75", "Issue": "3", "PubDate": {"Year": "2006"}}, "Title": "Psychotherapy and psychosomatics", "ISOAbbreviation": "Psychother Psychosom"}, "ArticleTitle": "Persistent sexual side effects after SSRI discontinuation.", "Pagination": {"StartPage": "187", "EndPage": "188", "MedlinePgn": "187-8"}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Csoka", "ForeName": "Antonei B", "Initials": "AB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Shipko", "ForeName": "Stuart", "Initials": "S"}], "PublicationTypeList": ["Case Reports", "Letter"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Psychother Psychosom", "NlmUniqueID": "0024046", "ISSNLinking": "0033-3190"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Androgens"}, {"RegistryNumber": "0", "NameOfSubstance": "Dopamine Agonists"}, {"RegistryNumber": "0", "NameOfSubstance": "Dopamine Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Ergolines"}, {"RegistryNumber": "0", "NameOfSubstance": "Monoamine Oxidase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Piperazines"}, {"RegistryNumber": "0", "NameOfSubstance": "Purines"}, {"RegistryNumber": "0", "NameOfSubstance": "Serotonin Uptake Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfones"}, {"RegistryNumber": "0", "NameOfSubstance": "Vasodilator Agents"}, {"RegistryNumber": "01K63SUP8D", "NameOfSubstance": "Fluoxetine"}, {"RegistryNumber": "01ZG3TPX31", "NameOfSubstance": "Bupropion"}, {"RegistryNumber": "0DHU5B8D6V", "NameOfSubstance": "Citalopram"}, {"RegistryNumber": "2K1V7GP655", "NameOfSubstance": "Selegiline"}, {"RegistryNumber": "3XMK78S47O", "NameOfSubstance": "Testosterone"}, {"RegistryNumber": "BW9B0ZE037", "NameOfSubstance": "Sildenafil Citrate"}, {"RegistryNumber": "LL60K9J05T", "NameOfSubstance": "Cabergoline"}, {"RegistryNumber": "QUC7NX6WMB", "NameOfSubstance": "Sertraline"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Androgens"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Anxiety"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Bupropion"}, {"QualifierName": [], "DescriptorName": "Cabergoline"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Citalopram"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depressive Disorder"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Dopamine Agonists"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Dopamine Uptake Inhibitors"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Ergolines"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Fluoxetine"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Monoamine Oxidase Inhibitors"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Piperazines"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Purines"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Selegiline"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Selective Serotonin Reuptake Inhibitors"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Sertraline"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Sexual Dysfunctions, Psychological"}, {"QualifierName": [], "DescriptorName": "Sildenafil Citrate"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Sleep Initiation and Maintenance Disorders"}, {"QualifierName": [], "DescriptorName": "Sulfones"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Testosterone"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": [], "DescriptorName": "Treatment Outcome"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Vasodilator Agents"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2006", "Month": "4", "Day": "26", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "10", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "4", "Day": "26", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["16636635", "10.1159/000091777", "91777"]}}], "PubmedBookArticle": []}